Home > Boards > US Listed > Medical - Healthcare >

Amylin Pharmaceuticals Inc. (AMLN)

AMLN RSS Feed
Add AMLN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 7/2/2012 2:54:24 PM - Followers: 13 - Board type: Free - Posts Today: 0

http://www.amylin.com

http://finance.yahoo.com/q/pr?s=AMLN

http://www.form4oracle.com/company?cik=0000881464&ticker=amln


Amylin Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of medicines for diabetes, obesity, and other diseases in the United States. It sells BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection for the treatment of patients with Type II diabetes. The company also has research and development programs in the therapeutic areas of diabetes and obesity, including exenatide once weekly; Nasal Exenatide, a nasal spray formulation of exenatide for diabetes; Pramlintide and PYY 3-36 for the treatment of obesity; Leptin for the treatment of obesity and lipodystrophy; Pramlintide-Metreleptin combination product candidate for overweight or obese subjects; and second generation Amylinomimetic for weight loss. It sells its products to healthcare providers, managed healthcare organizations, wholesalers and pharmacies, government purchasers, and other third-party payors. The company has collaboration agreements with Eli Lilly and Company, as well as with Alkermes, Inc. to develop exenatide once weekly for diabetes; a contract research arrangement with Kelaroo, Inc. for the commercialization of Kelaroo's SeqR technology that is used for peptide hormone identification and optimization; a joint research collaboration agreement with BioSeek, Inc. for discovery and development of novel peptide therapeutics for inflammatory conditions; and a joint research collaboration agreement with Xenome, Ltd. for discovery and development of novel peptide hormones for a range of metabolic and musculoskeletal diseases. It also has a collaboration with Pacira Pharmaceuticals, Inc. for the development of sustained release injectable products based on the DepoFoam technology platform. Amylin Pharmaceuticals was founded in 1987 and is based in San Diego, California.


AMLN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#167   Curious to see how the AMLN buyout compares DewDiligence 07/02/12 02:54:24 PM
#166   5:56AM Amylin Pharma to be acquired by Bristol-Myers surf1944 07/02/12 07:39:11 AM
#165   Bristol-Myers Squibb to Buy Amylin for $5.3 Billion http://www.cnbc.com/id/48 gixxer11 06/30/12 11:23:30 AM
#164   This will have heavy PM volume Monday :) gixxer11 06/30/12 11:21:40 AM
#163   12:59AM Amylin Pharma reports SYMLIN use helped patients surf1944 06/11/12 10:19:54 AM
#162   7 companies interested enough to sign confidentiality pacts north40000 05/15/12 01:29:07 PM
#161   7:13AM Amylin Pharma beats by $0.04, misses on surf1944 04/26/12 08:28:50 AM
#160   <<< $AMLN Links! >>> ~ MAC's Quick DD Penny Roger$ 04/26/12 05:59:53 AM
#159   ~ Thursday! $AMLN ~ Q1 Earnings posted, pending Penny Roger$ 04/26/12 05:59:41 AM
#158   Icahn Issues Statement Regarding Amylin Pharmaceuticals north40000 04/25/12 02:33:55 PM
#157   8:13AM Amylin Pharma: Carl Icahn confirms that he surf1944 04/04/12 09:25:51 AM
#154   History repeating? First down from 20 to 10 mlkrborn 03/28/12 01:39:10 PM
#153   Amilyn Soars on News of Spurned Bristol-Myers Bid surf1944 03/28/12 11:54:42 AM
#152   Amylin Pharma AMLN Canaccord Genuity Sell $12 surf1944 03/26/12 08:52:18 AM
#151   9:03AM Amylin Pharma announces pricing of public offering surf1944 03/08/12 10:32:01 AM
#150   7:55AM Amylin Pharma and Eli Lilly receive CHMP surf1944 02/17/12 08:32:33 AM
#149   Musings on Amylin-inVentiv Deal WID 02/10/12 03:44:35 PM
#148   ~ AMLN~ Jefferies believes Amylin's 2012 guidance suggests Pyckstocks 02/07/12 09:44:20 AM
#147   "Alkermes earned $0.3 million in royalty revenues from equity8 02/03/12 01:09:55 PM
#146   Recent insider buys Docsfixinit 01/30/12 10:32:43 AM
#145   Testing RESISTANCE !!!!!!!!!!!! Docsfixinit 01/30/12 10:15:49 AM
#144   $AMLN chart opinion: http://blog.chartmystock.com/2012/01/29/amln-amylin-fda-ap shankapotamus 01/29/12 03:07:54 PM
#143   $27.00 !!!!!!!!!!! Docsfixinit 01/28/12 03:08:02 PM
#142   I have 4 family members with type 2 Docsfixinit 01/27/12 05:59:28 PM
#141   FDA Approves BYDUREON(TM) -- The First and Only Docsfixinit 01/27/12 05:57:34 PM
#140   ALMN Shares Outstanding 137,241,585 a/o Jul 25, 2008 Docsfixinit 01/27/12 05:27:28 PM
#139   http://finance.yahoo.com/news/FDA-Approves-BYDUREON-The-prnews-2702238983.html?x Docsfixinit 01/27/12 05:26:52 PM
#138   BIG NEWS Docsfixinit 01/27/12 04:52:30 PM
#137   APPROVED oregon 1 01/27/12 02:45:32 PM
#136   Amylin Pharmaceuticals, Inc. (AMLN) surf1944 01/27/12 01:05:09 PM
#135   Avg Vol (3 month)3: 1,961,420 surf1944 11/30/11 03:12:44 PM
#134   AMLN $9.60 with "Blockbuster breakup: Amylin buys out mlkrborn 11/08/11 01:39:38 PM
#133   7:10AM Amylin Pharma, Eli Lilly (LLY), and Alkermes surf1944 09/12/11 08:13:05 AM
#132   1. AMYLIN PHARMACEUTICALS INC (AMLN): AMLN recently traded surf1944 09/05/11 10:47:19 PM
#131   7:39AM Amylin Pharma misses by $0.04, reports revs surf1944 07/26/11 08:13:40 AM
#130   Amylin, Alkermes say diabetes drug safe for heart surf1944 07/08/11 11:11:09 AM
#129   http://www.secform4.com/insider-trading/881464.htm surf1944 07/04/11 11:12:25 AM
#128   Once-Monthly Exenatide Improved Glucose Control in Patients with surf1944 07/04/11 11:11:52 AM
#127   The Diabetes Trade: Why We Like Amylin surf1944 07/04/11 11:10:18 AM
#126   http://www.nasdaq.com/asp/holdings.asp?symbol=AMLN&selected=AMLN&FormType=Instit surf1944 07/04/11 11:09:21 AM
#125   Bob... this could be a good play for trade2much 04/15/11 06:28:33 PM
#124   Picked up this from a news blast this morning BobStockguy 04/15/11 09:45:27 AM
#123   8:02AM Amylin Pharma and Takeda voluntarily suspend clinical surf1944 03/16/11 10:46:58 AM
#122   8:01AM Amylin Pharma, Eli Lilly (LLY) and Alkermes surf1944 03/10/11 01:04:32 PM
#121   Bloomberg article...possible buyout??....Lilly's Diabetes Setbacks May Spur Sho Blutribe 10/24/10 12:20:30 PM
#119   SAN DIEGO, INDIANAPOLIS and WALTHAM, Mass., Oct 19, mlkrborn 10/20/10 10:45:04 AM
#118   Amylin Pharmaceuticals Announces Third Quarter Product Revenues; Quarterly mlkrborn 10/20/10 10:39:51 AM
#117   AMLN: Down $10 to $10. mlkrborn 10/20/10 10:15:10 AM
#115   Deutsche Bank Maintains a 'Buy' on Amylin Pharmaceuticals Volume 09/25/10 06:03:26 PM
#114   Rumor: Amylin spikes up on renewed takeover speculation Volume 09/22/10 08:31:41 PM
PostSubject